189 related articles for article (PubMed ID: 22710069)
1. Rotenone-induced parkinsonism elicits behavioral impairments and differential expression of parkin, heat shock proteins and caspases in the rat.
Sonia Angeline M; Chaterjee P; Anand K; Ambasta RK; Kumar P
Neuroscience; 2012 Sep; 220():291-301. PubMed ID: 22710069
[TBL] [Abstract][Full Text] [Related]
2. Sesamol and naringenin reverse the effect of rotenone-induced PD rat model.
Sonia Angeline M; Sarkar A; Anand K; Ambasta RK; Kumar P
Neuroscience; 2013 Dec; 254():379-94. PubMed ID: 24070629
[TBL] [Abstract][Full Text] [Related]
3. Long-term heat shock proteins (HSPs) induction by carbenoxolone improves hallmark features of Parkinson's disease in a rotenone-based model.
Thakur P; Nehru B
Neuropharmacology; 2014 Apr; 79():190-200. PubMed ID: 24296154
[TBL] [Abstract][Full Text] [Related]
4. α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment.
George S; Mok SS; Nurjono M; Ayton S; Finkelstein DI; Masters CL; Li QX; Culvenor JG
J Mol Neurosci; 2010 Oct; 42(2):243-54. PubMed ID: 20464527
[TBL] [Abstract][Full Text] [Related]
5. Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease.
Carriere CH; Kang NH; Niles LP
Brain Res; 2016 Feb; 1633():115-125. PubMed ID: 26740407
[TBL] [Abstract][Full Text] [Related]
6. Blockade of metabotropic glutamate receptor 5 protects against DNA damage in a rotenone-induced Parkinson's disease model.
Xia N; Zhang Q; Wang ST; Gu L; Yang HM; Liu L; Bakshi R; Yang H; Zhang H
Free Radic Biol Med; 2015 Dec; 89():567-80. PubMed ID: 26454081
[TBL] [Abstract][Full Text] [Related]
7. Flavin-containing monooxygenase, a new clue of pathological proteins in the rotenone model of parkinsonism.
Li B; Yuan Y; Zhang W; He W; Hu J; Chen N
Neurosci Lett; 2014 Apr; 566():11-6. PubMed ID: 24440618
[TBL] [Abstract][Full Text] [Related]
8. Thymoquinone exerts neuroprotective effect in animal model of Parkinson's disease.
Ebrahimi SS; Oryan S; Izadpanah E; Hassanzadeh K
Toxicol Lett; 2017 Jul; 276():108-114. PubMed ID: 28526446
[TBL] [Abstract][Full Text] [Related]
9. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
[TBL] [Abstract][Full Text] [Related]
11. Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease.
Saravanan KS; Sindhu KM; Mohanakumar KP
Brain Res; 2005 Jul; 1049(2):147-55. PubMed ID: 15936733
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone.
Mulcahy P; Walsh S; Paucard A; Rea K; Dowd E
Neuroscience; 2011 May; 181():234-42. PubMed ID: 21277943
[TBL] [Abstract][Full Text] [Related]
13. Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats.
Karuppagounder SS; Madathil SK; Pandey M; Haobam R; Rajamma U; Mohanakumar KP
Neuroscience; 2013 Apr; 236():136-48. PubMed ID: 23357119
[TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: An investigation into the interaction of parkin and Drp1 proteins.
Rahimmi A; Khosrobakhsh F; Izadpanah E; Moloudi MR; Hassanzadeh K
Brain Res Bull; 2015 Apr; 113():34-40. PubMed ID: 25732239
[TBL] [Abstract][Full Text] [Related]
15. REM sleep deprivation generates cognitive and neurochemical disruptions in the intranigral rotenone model of Parkinson's disease.
Dos Santos AC; Castro MA; Jose EA; Delattre AM; Dombrowski PA; Da Cunha C; Ferraz AC; Lima MM
J Neurosci Res; 2013 Nov; 91(11):1508-16. PubMed ID: 23908011
[TBL] [Abstract][Full Text] [Related]
16. Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.
Lin CH; Huang JY; Ching CH; Chuang JI
J Pineal Res; 2008 Mar; 44(2):205-13. PubMed ID: 18289173
[TBL] [Abstract][Full Text] [Related]
17. Effects of Aging in the Striatum and Substantia Nigra of a Parkinson's Disease Animal Model.
Ureshino RP; Costa AJ; Erustes AG; Pereira GJDS; Sinigaglia-Coimbra R; Smaili SS
Toxicol Pathol; 2018 Apr; 46(3):348-358. PubMed ID: 29683090
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin A1 inhibits rotenone-induced apoptosis in SH-SY5Y cells.
Wang X; Qin ZH; Leng Y; Wang Y; Jin X; Chase TN; Bennett MC
J Neurochem; 2002 Dec; 83(5):1094-102. PubMed ID: 12437580
[TBL] [Abstract][Full Text] [Related]
20. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease.
Duan W; Mattson MP
J Neurosci Res; 1999 Jul; 57(2):195-206. PubMed ID: 10398297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
